Artificial intelligence and machine learning are proving to be meaningful weapons in our arsenal during the coronavirus crisis.
With the Covid-19 pandemic increasingly forcing healthcare testing, diagnosis and treatment online, the promise of augmented and virtual reality is drawing deepening interest in Asia’s medtech market.
Medtech companies must account for a more complex web of influencers on purchasing.
How manufacturers can better understand their customers in a rapidly changing provider environment.
Are digital technologies actually getting in the way of effectively treating patients?
Discussing device problems can have a serious affect on patients. Physicians, manufacturers, and FDA should clarify their message to maintain trust.